Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Company Questions Remain Unanswered In FDA's Combo Products GMP Rule

This article was originally published in The Pink Sheet Daily

Executive Summary

Agency's proposed "streamlined approach" to combination product manufacturing raises a number of practical questions, such as what elements are actual components of a combo product and at what stage the streamlined system kicks in, firms say.

You may also be interested in...



FDA’s Combo Product GMP Reg Speeds Ahead Unchanged

Agency decides to keep the proposed rule, issued in 2009, “largely identical” and denies requests to delay implementation a year.

FDA’s Combo Product GMP Reg Speeds Ahead Unchanged

Agency decides to keep the proposed rule, issued in 2009, “largely identical” and denies requests to delay implementation a year.

Proposed Rule Defines Good Manufacturing Practices For Combo Products

FDA released its long-awaited proposed rule on good manufacturing practices for combination products Sept. 22

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS070144

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel